Stocks to sell

Canoo (NASDAQ:GOEV) closed its SPAC (special purpose acquisition company) merger on Dec. 21, 2020, and received $607 million. Since then, however, GOEV stock has dropped precipitously. Source: Shutterstock In fact, Canoo has not announced the production partners for its Canoo lifestyle electric vehicle (EV). Maybe this has something to do with the fall in GOEV
0 Comments
Rationality is coming back to the pricing of Zomedica (NYSEAMERICAN:ZOM) stock. Source: Postmodern Studio / Shutterstock.com Investors may have been highly bullish on the prospects of Truforma, the company’s veterinary diagnostics platform. But trading leaps and bounds above the potential long-term upside from this catalyst, it was inevitable shares were going to pull back in
0 Comments
American Airlines Group Inc. (NASDAQ:AAL) is the “largest airline in the world in terms of revenue passenger mile, scheduled passengers carried, and fleet size” according to ZIPPIA. Furthermore, the airline industry and travel industry are set to recover rapidly in 2021, as there is a global vaccination program to put an end to the novel
0 Comments
President Biden’s proposed $2 trillion infrastructure plan was just what ChargePoint (NYSE:CHPT) needed. CHPT stock saw an awesome rally on this news. And, with $174 billion of the bill proposed for electric vehicles (including charging stations), it’s not a surprise that investors took the news and ran with it. Source: YuniqueB / Shutterstock.com Yet, after
0 Comments
Shares of up-and-coming electric vehicle company Lordstown Motors (NASDAQ:RIDE) stock have tanked 40% this month. Source: SevenMaps / ShutterStock.com Short-seller Hindenburg Research is on its case again, alleging that the company has greatly exaggerated the pre-orders for its Endurance electric pickup truck. The SEC has now decided to investigate the matter. Subsequently, several firms and
0 Comments
The story underpinning Bionano Genomics (NASDAQ:BNGO) stock unquestionably is intriguing. Bionano claims to offer a substantial improvement in genome analysis that enables more patients to be correctly diagnosed and treated. Source: Connect world / Shutterstock.com If the company is right and its technology truly is that disruptive, then BNGO stock should climb, and it could
0 Comments